Skip to main content
. 2022 Oct 12;57(2):154–158. doi: 10.1177/15385744221132136

Table 3.

Surgical Outcomes Following Introduction of the Stepwise Haemostasis Pathway.

Pre-protocol Post-protocol P value, OR [95% CI)
Haematoma rate 10 (10%) 3 (2.6%) P = .02, OR: 0.25 (95% CI .07-.94)
Return to theatre 6 (6%) 1 (.9%) P = .03, OR: 0.14 (95% CI .02-1.19)
Perioperative TIA/stroke rate 9 (9%) 3 (2.7%) P = .03, OR: 0.28 (95% CI .07-1.06)
30 d stroke and death rate 5 (5%) 2 (1.8%) P = .11, OR: 0.35 (95% CI .07-1.82)
Significant cranial nerve damage (30 d) 1 (1%) 0 P = .29
Acute coronary syndrome 2 (2%) 1 (1%) P = .25, OR: 0.44 (95% CI .04-4.94)
Post operation length of stay (>2 d) 33 (33%) 46 (41%) P = .15, OR: 1.34 (95% CI .77-2.38)